An investigational triple agonist of GLP-1, GIP, and glucagon receptors researched for effects on metabolism and body-weight regulation.
Retatrutide is an investigational peptide designed to activate three receptors simultaneously: GLP-1, GIP, and glucagon. Research examines this triple-agonist mechanism for its combined effects on energy expenditure, appetite signalling, and glucose and lipid metabolism in preclinical and exploratory model systems.
It is among the most studied of the newer multi-receptor metabolic agonists. It is a research-only investigational compound.
Studied for simultaneous activation of GLP-1, GIP, and glucagon receptor pathways.
Researched for glucagon-driven effects on energy expenditure in metabolic models.
Examined for incretin-mediated influence on appetite and food-intake pathways.
Investigated for combined effects on glucose and lipid handling in preclinical work.
Bring the vial (10 mg · 20 mg) and bacteriostatic water to room temperature.
Add bacteriostatic water slowly along the glass wall — the volume you add sets the concentration.
Swirl gently (do not shake) until fully clear, then refrigerate at 2–8 °C.
Studied together to model incretin agonism alongside amylin-receptor appetite signalling.
Compared in research contrasting triple- versus dual-receptor incretin mechanisms.
Links open a PubMed search for the topic. They point to independent literature and are provided for orientation in a research context only.
Research studies it as a single peptide activating GLP-1, GIP, and glucagon receptors together, allowing investigation of combined incretin and glucagon signalling on metabolism and body-weight regulation in models.
Unlike dual GLP-1/GIP agonists, Retatrutide adds glucagon-receptor activity, which research examines for additional effects on energy expenditure alongside appetite and glucose signalling.
No. It is an investigational research compound studied in exploratory and preclinical metabolic model systems, with no established approved therapeutic use in this context.
You must be at least 21 years old to enter this website.
By clicking "Confirm & Enter", you confirm that you are 21 years of age or older and understand that all products sold on this website are intended for research purposes only.
